» Articles » PMID: 38248363

Impact of Non-Surgical Periodontal Treatment on the Concentration and Level of MRP-8/14 (Calprotectin) As an Inflammatory Biomarker in Women with Periodontitis and Rheumatoid Arthritis: A Quasi-Experimental Study

Abstract

The aim of this study was to evaluate the impact of non-surgical periodontal treatment (NS-PT) on periodontal parameters and inflammatory biomarkers in the concentration and level of calprotectin (CLP) in women with periodontitis and rheumatoid arthritis (RA). In this quasi-experimental study, we evaluated 30 women (mean age: 52.0 ± 5.8 years) with periodontitis and RA who had been diagnosed and treated for RA for more than 3 years and whose activity markers remained at similar values without significant reduction over three consecutive months. Patients underwent NS-PT, which included plaque control, scaling, and root planing. Serum and saliva samples, periodontal indices, RA activity markers, Disease Activity Score-28 (DAS28), the erythrocyte sedimentation rate (ESR), and the C-reactive protein (CRP) and CLP contents were measured at the beginning of the study and 6 and 12 weeks after NS-PT. Parametric and nonparametric tests were used in the analysis. The mean age was 52.0 ± 5.8 years. Compared to the baseline results, all periodontal indices were significantly reduced 6 and 12 weeks after NS-PT ( < 0.001). DAS28 was also significantly reduced after 12 weeks ( < 0.0001). Similarly, the serum CLP concentration decreased 6 and 12 weeks after NS-PT ( < 0.0001). Of the patients, 100% presented lower levels of CRP and ESR ( < 0.0001). Overall, NS-PT reduced inflammation and disease activity, highlighting the importance of oral health in the control and treatment of systemic diseases such as RA and confirming that NS-PT effectively reduces periodontitis activity and plays a key role in modulating RA activity. Therefore, NS-PT should be considered as an adjunct treatment for RA.

Citing Articles

Inflammation: The Cause of All Diseases.

Chavda V, Feehan J, Apostolopoulos V Cells. 2024; 13(22).

PMID: 39594654 PMC: 11592557. DOI: 10.3390/cells13221906.

References
1.
Iwashita M . Association between Periodontal Disease and Arteriosclerosis-Related Diseases. J Atheroscler Thromb. 2023; 30(11):1517-1524. PMC: 10627774. DOI: 10.5551/jat.RV22010. View

2.
Zhao X, Liu Z, Shu D, Xiong Y, He M, Xu S . Association of Periodontitis with Rheumatoid Arthritis and the Effect of Non-Surgical Periodontal Treatment on Disease Activity in Patients with Rheumatoid Arthritis. Med Sci Monit. 2018; 24:5802-5810. PMC: 6113853. DOI: 10.12659/MSM.909117. View

3.
de Smit M, Brouwer E, Vissink A, van Winkelhoff A . Rheumatoid arthritis and periodontitis; a possible link via citrullination. Anaerobe. 2011; 17(4):196-200. DOI: 10.1016/j.anaerobe.2011.03.019. View

4.
Newbrun E . Indices to measure gingival bleeding. J Periodontol. 1996; 67(6):555-61. DOI: 10.1902/jop.1996.67.6.555. View

5.
Jarlborg M, Courvoisier D, Lamacchia C, Martinez Prat L, Mahler M, Bentow C . Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis. Arthritis Res Ther. 2020; 22(1):105. PMC: 7201559. DOI: 10.1186/s13075-020-02190-3. View